About Us
Key Management
Services
Business Advisory
Business Opportunity
Markets/Economy
Contact Us
You Are On
Equity
Equity Analysis
Price
Gainers & Losers
Weekly Gainers & Losers
Monthly Gainers & Losers
Out & Under Performers
Advances & Declines
New Highs & Lows
52 Week Highs & Lows
Only Buyers & Sellers
Historical Returns
Circuit Breaker
Volume
Volume
Value
Block Deals
Bulk Deals
Highest & Lowest Delivery
Analysis
5 Day's Up & Down
Contribution to Index
Live Indices
Rising VDP
Rising VD & Falling Price
Price Shockers
Volume Shockers
Delivery Shockers
Sector Watch
Exchange Holidays
Exchange Holidays
News Analysis
Hot Stocks
Opening Bell
Midday Review
Closing Bell
Other Market
Corporate News
Market Pulse
Economy
Result Announcements
Global Markets
Current Affairs & Politics
Mutual Funds News
Corporate News
Corporate Action
BSE Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Split of Face Value
Dividend Details
Delisted Companies
Change of Name
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Cash Flow
Shareholdings
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Peer Comparison
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Annoucements
Book Closure
Record Date
Bonus Issues
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
AGM
Derivatives
Derivatives
Get Quotes
Nifty Futures
FII Statistics
Put Call Ratio
Most Active Calls
Most Active Puts
List of Underlying
Daily Settlement Price
Derivatives Summary
Derivatives News
Market Report
Top Gainers
Top Losers
Top Value
Top Volume
All Index Futures
Most Active Contracts
Overview
Contracts Available
PL & Current OI
Open Interest
Basis In Futures
Other Market
FII Activities
DII Investments
Global Indices
ADR Prices
Research
Daily Morning Note
Technical Weekly
Fundamental-Sector
Fundamental-Company
Company News
Glenmark Pharmaceuticals Ltd.
BSE Code
532296
ISIN Demat
INE935A01035
Book Value
868.32
NSE Code
GLENMARK
Dividend Yield %
0.11
Market Cap
615635.17
P/E
38.23
EPS
57.06
Face Value
1
1 Week
1 Month
3 Months
6 Months
1 Year
11-Jul-2025
Glenmark Pharmaceuticals’ arm enters into licensi...
11-Jul-2025
Glenmark Pharmaceuticals zooms as its arm enters ...
01-Jul-2025
Glenmark Pharmaceuticals informs about details of...
24-Jun-2025
Glenmark Pharmaceuticals launches TEVIMBRA in Ind...
24-Jun-2025
Glenmark Pharmaceuticals informs about media rele...
24-Jun-2025
Glenmark Pharmaceuticals rises on launching TEVIM...
19-Jun-2025
Glenmark Pharmaceuticals informs about disclosure
18-Jun-2025
USFDA concludes GMP inspection at Glenmark Pharma...
18-Jun-2025
Glenmark Pharmaceuticals informs about updates
18-Jun-2025
Glenmark Pharmaceuticals rises on the BSE
09-Jun-2025
Glenmark Pharmaceuticals to launch zanubrutinib i...
09-Jun-2025
Glenmark Pharmaceuticals informs about media rele...
26-May-2025
Glenmark Pharmaceuticals reports consolidated net...
22-May-2025
Intimation Of Grant Of Options Under 'Glenmark P...
19-May-2025
Glenmark Pharmaceutical informs about earnings ca...
Page
1
of
5
Prev
||
Next
RMS
|
Policies & Procedures
|
PMLA
|
Disclaimer
|
Privacy Policy
|
Web Mail
|
Relationship
|
Investor Grievance
Career
|
Contact Us
|
KYC
|
PMS Risk Disclosure
|
Key Managerial Person
|
Basic Details
|
Process of Opening an Account
|
Process of Filing Complaint
Links to MCX
|
NCDEX
|
FMC
|
NCDEX CMID NCDEX-CO-04-00129
|
MCX 10550
|
FMC MCX: MCX/TCM/CORP/0008
|
FMC NCDEX : NCDEX/TCM/CORP/0274
NSE: INB230914036
|
NSE F & O INF230914036
|
BSE: INB010914032
|
BSE F & O: INF010914032
|
CDSL: IN-DP-CDSL-335-2006
|
OTC: INB200914032
Related Sites:
Bombay Stock Exchange (BSE)
,
Investor Protection
,
National Stock Exchange (NSE)
,
Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By
Accord Fintech Pvt. Ltd.
